Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell Carcinoma.
Attalla K, DiNatale RG, Rappold PM, Fong CJ, Sanchez-Vega F, Silagy AW, Weng S, Coleman J, Lee CH, Carlo MI, Durack JC, Solomon SB, Reuter VE, Russo P, Chan TA, Motzer RJ, Schultz ND, Reznik E, Voss MH, Hakimi AA. Attalla K, et al. Clin Cancer Res. 2021 Oct 15;27(20):5595-5606. doi: 10.1158/1078-0432.CCR-20-4058. Epub 2021 Jul 14. Clin Cancer Res. 2021. PMID: 34261695 Free PMC article.
The Association Between Small Primary Tumor Size and Prognosis in Metastatic Renal Cell Carcinoma: Insights from Two Independent Cohorts of Patients Who Underwent Cytoreductive Nephrectomy.
DiNatale RG, Xie W, Becerra MF, Silagy AW, Attalla K, Sanchez A, Mano R, Marcon J, Blum KA, Benfante NE, Voss MH, Motzer RJ, Coleman J, Choueiri TK, Reznik E, Russo P, Heng DYC, Hakimi AA. DiNatale RG, et al. Among authors: attalla k. Eur Urol Oncol. 2020 Feb;3(1):47-56. doi: 10.1016/j.euo.2019.10.002. Epub 2019 Nov 14. Eur Urol Oncol. 2020. PMID: 31735646 Free PMC article.
Putative Drivers of Aggressiveness in TCEB1-mutant Renal Cell Carcinoma: An Emerging Entity with Variable Clinical Course.
DiNatale RG, Gorelick AN, Makarov V, Blum KA, Silagy AW, Freeman B, Chowell D, Marcon J, Mano R, Sanchez A, Attalla K, Weng S, Voss M, Motzer RJ, Russo P, Coleman JA, Reuter VE, Chen YB, Chan TA, Reznik E, Tickoo SK, Hakimi AA. DiNatale RG, et al. Among authors: attalla k. Eur Urol Focus. 2021 Mar;7(2):381-389. doi: 10.1016/j.euf.2019.11.013. Epub 2019 Dec 6. Eur Urol Focus. 2021. PMID: 31813809 Free PMC article.
Impact of intraoperative opioid and adjunct analgesic use on renal cell carcinoma recurrence: role for onco-anaesthesia.
Silagy AW, Hannum ML, Mano R, Attalla K, Scarpa JR, DiNatale RG, Marcon J, Coleman JA, Russo P, Tan KS, Fischer GW, McCormick PJ, Ari Hakimi A, Mincer JS. Silagy AW, et al. Among authors: attalla k. Br J Anaesth. 2020 Nov;125(5):e402-e404. doi: 10.1016/j.bja.2020.06.036. Epub 2020 Jul 21. Br J Anaesth. 2020. PMID: 32703551 Free PMC article. No abstract available.
The Clinicopathologic and Molecular Landscape of Clear Cell Papillary Renal Cell Carcinoma: Implications in Diagnosis and Management.
Weng S, DiNatale RG, Silagy A, Mano R, Attalla K, Kashani M, Weiss K, Benfante NE, Winer AG, Coleman JA, Reuter VE, Russo P, Reznik E, Tickoo SK, Hakimi AA. Weng S, et al. Among authors: attalla k. Eur Urol. 2021 Apr;79(4):468-477. doi: 10.1016/j.eururo.2020.09.027. Epub 2020 Oct 10. Eur Urol. 2021. PMID: 33046271 Free PMC article.
Prognostic models in papillary renal cell carcinoma.
Attalla K, Voss MH, Hakimi AA. Attalla K, et al. Ann Transl Med. 2020 Nov;8(21):1334. doi: 10.21037/atm-20-3750. Ann Transl Med. 2020. PMID: 33313079 Free PMC article. No abstract available.
A qualitative framework of non-selection factors for cytoreductive nephrectomy.
Silagy AW, Attalla K, Dinatale RG, Weiss KL, Weng S, Mano R, Iosepovici S, Marcon J, Reznik E, Kotecha RR, Motzer RJ, Voss MH, Coleman JA, Hakimi AA, Russo P. Silagy AW, et al. Among authors: attalla k. World J Urol. 2021 Sep;39(9):3359-3365. doi: 10.1007/s00345-021-03650-4. Epub 2021 Mar 29. World J Urol. 2021. PMID: 33779820 Free PMC article.
44 results